180 related articles for article (PubMed ID: 19211508)
1. Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment.
Swee LK; Bosco N; Malissen B; Ceredig R; Rolink A
Blood; 2009 Jun; 113(25):6277-87. PubMed ID: 19211508
[TBL] [Abstract][Full Text] [Related]
2. Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation.
Gauthier SD; Leboeuf D; Manuguerra-Gagné R; Gaboury L; Guimond M
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1721-31. PubMed ID: 26151303
[TBL] [Abstract][Full Text] [Related]
3. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
[TBL] [Abstract][Full Text] [Related]
4. Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
Hennies CM; Reboulet RA; Garcia Z; Nierkens S; Wolkers MC; Janssen EM
Clin Exp Immunol; 2011 Mar; 163(3):381-91. PubMed ID: 21235535
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell homeostasis is maintained by nonhematopoietic and T-cell-produced Flt3-ligand in steady state and during immune responses.
Saito Y; Boddupalli CS; Borsotti C; Manz MG
Eur J Immunol; 2013 Jun; 43(6):1651-8. PubMed ID: 23519969
[TBL] [Abstract][Full Text] [Related]
6. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
[TBL] [Abstract][Full Text] [Related]
7. Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease.
Teshima T; Reddy P; Lowler KP; KuKuruga MA; Liu C; Cooke KR; Ferrara JL
Blood; 2002 Mar; 99(5):1825-32. PubMed ID: 11861301
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.
McKenna HJ; Stocking KL; Miller RE; Brasel K; De Smedt T; Maraskovsky E; Maliszewski CR; Lynch DH; Smith J; Pulendran B; Roux ER; Teepe M; Lyman SD; Peschon JJ
Blood; 2000 Jun; 95(11):3489-97. PubMed ID: 10828034
[TBL] [Abstract][Full Text] [Related]
9. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death.
Molina MS; Hoffman EA; Stokes J; Kummet N; Smith KA; Baker F; Zúñiga TM; Simpson RJ; Katsanis E
Front Immunol; 2021; 12():699128. PubMed ID: 34249005
[TBL] [Abstract][Full Text] [Related]
11. CD8α⁺ dendritic cells improve collagen-induced arthritis in CC chemokine receptor (CCR)-2 deficient mice.
Ibarra JM; Quinones MP; Estrada CA; Jimenez F; Martinez HG; Ahuja SS
Immunobiology; 2011 Sep; 216(9):971-8. PubMed ID: 21531476
[TBL] [Abstract][Full Text] [Related]
12. Fms-like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow-derived CD117⁺ hematopoietic progenitor cells.
Xu Y; Jiang D; Hu Y; Li Y; Zhang X; Wang J; Wang Y
Mol Med Rep; 2015 Nov; 12(5):6969-75. PubMed ID: 26397863
[TBL] [Abstract][Full Text] [Related]
13. Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis.
Dupont CD; Harms Pritchard G; Hidano S; Christian DA; Wagage S; Muallem G; Tait Wojno ED; Hunter CA
J Immunol; 2015 Nov; 195(9):4369-77. PubMed ID: 26385522
[TBL] [Abstract][Full Text] [Related]
14. Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.
Hassan M; Ulezko Antonova A; Li JM; Hosoba S; Rupji M; Kowalski J; Perricone AJ; Jaye DL; Marsh H; Yellin M; Devine S; Waller EK
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1075-1084. PubMed ID: 30503387
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
[TBL] [Abstract][Full Text] [Related]
16. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells.
Zhan Y; Vega-Ramos J; Carrington EM; Villadangos JA; Lew AM; Xu Y
Eur J Immunol; 2012 Nov; 42(11):2889-900. PubMed ID: 22806691
[TBL] [Abstract][Full Text] [Related]
17. Impaired thymic negative selection causes autoimmune graft-versus-host disease.
Teshima T; Reddy P; Liu C; Williams D; Cooke KR; Ferrara JL
Blood; 2003 Jul; 102(2):429-35. PubMed ID: 12663438
[TBL] [Abstract][Full Text] [Related]
18. FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: role of pneumolysin.
Brumshagen C; Maus R; Bischof A; Ueberberg B; Bohling J; Osterholzer JJ; Ogunniyi AD; Paton JC; Welte T; Maus UA
Infect Immun; 2012 Dec; 80(12):4281-90. PubMed ID: 23006850
[TBL] [Abstract][Full Text] [Related]
19. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice.
Pawlowska AB; Hashino S; McKenna H; Weigel BJ; Taylor PA; Blazar BR
Blood; 2001 Mar; 97(5):1474-82. PubMed ID: 11222396
[TBL] [Abstract][Full Text] [Related]
20. No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand-deficient mice.
Walzer T; Brawand P; Swart D; Tocker J; De Smedt T
J Allergy Clin Immunol; 2005 Jan; 115(1):192-9. PubMed ID: 15637568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
